Showing results (651-660 of 2,688) with videos related to

Sort By:
Pageof 269
The Lancet. Infectious Diseases|April 24, 2026
The impact of clinical metagenomic testing on patient management: facts versus fantasyJulianne R Brown, Charles Y Chiu, F Xavier López-Labrador, et al.
The Lancet. Infectious Diseases|December 1, 2019
Ethical implications of recruiting universal stool donors for faecal microbiota transplantationMoiz Mikail, Kieran C O'Doherty, Susan M Poutanen, et al.
The Lancet. Infectious Diseases|June 15, 2026
Effect of a community-based behavioural intervention bundle to improve antibiotic use and patient management in Burkina Faso and DR Congo (CABU-EICO): a cluster-randomised controlled trialBrecht Ingelbeen, Daniel Valia, Bijou Mbangi, et al.
The Lancet. Infectious Diseases|May 28, 2011
Use of benchmarking and public reporting for infection control in four high-income countriesThomas Haustein, Petra Gastmeier, Alison Holmes, et al.
The Lancet. Infectious Diseases|December 23, 2023
Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trialYoshiaki Oda, Yuji Kumagai, Manabu Kanai, et al.
The Lancet. Infectious Diseases|July 8, 2026
Efficacy and safety of rivaroxaban, colchicine, and famotidine-loratadine with specialist supportive clinical care for fatigue in patients with post-COVID-19 condition in the UK: a multisite, open-label, randomised controlled trial
The Lancet. Infectious Diseases|June 18, 2026
Neutralising antibody responses to MPXV clades Ia, Ib, and IIb after infection or vaccination: a multicountry observational studyJameson Crandell, Raianna F Fantin, Leonardo Pereira de Araújo, et al.
The Lancet. Infectious Diseases|February 24, 2007
Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysisBenjamin M P Tang, Guy D Eslick, Jonathan C Craig, et al.
The Lancet. Infectious Diseases|July 29, 2026
Impact of directly observed treatment and extended age range of seasonal malaria chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine in Burkina Faso: a three-group, open-label, cluster-randomised, controlled trialJean Baptiste Yaro, Alphonse Ouedraogo, Marta Moreno, et al.
The Lancet. Infectious Diseases|August 19, 2026
Epidemiological impact of a dual-action insecticidal coating applied to Aedes aegypti breeding sites on dengue transmission in Colombia: a cluster-randomised trialRocio Cardenas, Axel Kroeger, Max Petzold, et al.
Pageof 269